Federal Agency · National Institutes of Health
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Last updated: November 6, 2026
Posted October 31, 2024
- Who can apply
- See eligibility below
- Amount
- Not specified — see source
- Deadline
- June 2, 2027 · 207 days remaining
- Where
- Nationwide
- Status
- Open
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses.
This NOFO will support studies to assess the ability of the unique patterns of host biology (e.g., native microbiome, immune system, gender, diet, age, genetic background, lifestyle, and health history) that are correlated with probiotic usage to detect the improvement of probiotic responsiveness. Well-suited applications must offer rigorously designed mechanistic studies using relevant/innovative animal models or in human subjects. This NOFO is intended to support projects where potential host biological patterns that are correlated with probiotic usage have been identified, as demonstrated with supportive preliminary data, but require further mechanistic studies to test for their causality or predictability. Applicants pursuing early-stage research to identify host biological patterns that may affect probiotic health outcomes should consider the companion (R61/R33) NOFO PAR-AT-24-XXX (TEMP-25412).
Focus area
- Funded by NIH
NAICS: 541714, 621111, 621112, 622
Award details
Applications close on June 2, 2027 (207 days remaining).
Categories
Not categorized
Grants.gov ↗·Last verified November 6, 2026
Similar grants
- Balanced Prosecution of Transnational Organized Crime CasesBureau of International Narcotics-Law Enforcement · closes November 9, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)National Institutes of Health · closes November 9, 2026
- Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319Environmental Protection Agency · closes November 9, 2026
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)National Institutes of Health · closes November 9, 2026
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)National Institutes of Health · closes November 10, 2026
- ROSES25: C.4 Planetary Science Enabling FacilitiesNASA Headquarters · closes November 10, 2026
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)National Institutes of Health · closes November 10, 2026
- BJA FY26 Paul Coverdell Forensic Science Improvement - Formula Grants ProgramBureau of Justice Assistance · closes November 10, 2026
